These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7437318)

  • 1. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophils.
    Majewski S; Jabłonska S; Langner A; Pawinska M; Szmurło A
    Br J Dermatol; 1985 Jun; 112(6):655-62. PubMed ID: 4038367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
    Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
    Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear leukocyte random migration and chemotaxis in psoriatic and healthy adult smokers and non-smokers.
    Sonnex TS; Carrington P; Norris P; Greaves MW
    Br J Dermatol; 1988 Nov; 119(5):653-9. PubMed ID: 3207619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo mobilization of polymorphonuclear leukocytes in psoriasis: relationship to clinical parameters and serum inhibitory factors.
    Tigalonowa M; Glinski W; Jablonska S
    J Invest Dermatol; 1983 Jul; 81(1):6-9. PubMed ID: 6863981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients.
    Fräki JE; Jakoi L; Davies AO; Lefkowitz RJ; Snyderman R; Lazarus GS
    J Invest Dermatol; 1983 Sep; 81(3):254-7. PubMed ID: 6309987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
    Lundin A; Håkansson L; Michaëlsson G; Venge P
    Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis and leukocyte chemotaxis.
    Tagami H; Iwatsuki K; Takematsu H
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients.
    Bunse T; Mahrle G
    Acta Derm Venereol; 1996 Jan; 76(1):10-2. PubMed ID: 8721481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?
    Langner A; Chorzelski TP; Fraczykowska M; Jabłońska S; Symańczyk
    Arch Dermatol Res; 1983; 275(4):226-8. PubMed ID: 6625647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses.
    Schröder JM; Szperalski B; Koh CJ; Christophers E
    J Invest Dermatol; 1981 Dec; 77(6):464-8. PubMed ID: 7310170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian rhythm of the in vivo migration of neutrophils in psoriatic patients.
    Pigatto PD; Radaelli A; Tadini G; Polenghi MM; Brambilla L; Altomare G; Carandente F
    Arch Dermatol Res; 1985; 277(3):185-9. PubMed ID: 4015183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of monocyte chemotactic activity in the sera of psoriatic patients after heat treatment.
    Isoda M; Hidaka K
    J Dermatol; 1987 Feb; 14(1):29-32. PubMed ID: 3301947
    [No Abstract]   [Full Text] [Related]  

  • 15. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphonuclear leukocyte function in psoriasis vulgaris.
    Pease CT; Fennell M; Staughton RC; Brewerton DA
    Br J Dermatol; 1987 Aug; 117(2):161-7. PubMed ID: 3651338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functions of polymorphonuclear leukocytes emigrating into the skin.
    Csato M; Dobozy A; Raith L; Simon N
    Acta Derm Venereol; 1985; 65(2):106-10. PubMed ID: 2408410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neutrophil granulocyte chemotaxis and psoriasis].
    Christophers E; Schröder JM
    Hautarzt; 1981 Nov; 32(11):558-63. PubMed ID: 6458581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.